Techosta Where Tech Starts From
In this week’s episode of Industry Focus: Healthcare, host Shannon Jones and Motley Fool analyst Brian Feroldi dive into earnings from four medical device makers — two that crushed it and two that tanked. Abiomed‘s (NASDAQ:ABMD) FDA concerns proved too big for the company to deal with quietly, and that hurt this quarter. Intersect ENT‘s (NASDAQ:XENT) promising devices were overshadowed by some big and growing concerns about long-term ... Read More »
2 Winners and 2 Losers in the Med Tech Market This Quarter
